GlassScriptPhysician profile
Jorge L Cuza
NPI 1245289917
$2,811.89
in general payments reported to CMS, 2019-2025
17 companies · $137 in 2025
The $137 reported for 2025 was less than what a typical Foot Surgery provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $483 · 2020: $1,157 · 2021: $415 · 2022: $64.78 · 2023: $428 · 2024: $128 · 2025: $137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $693.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $693.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $1,213.09 | 2020-2025 | |
| Horizon Therapeutics Plc | $421.39 | 2019-2023 | Krystexxa |
| Smith+Nephew, INC. | $245.87 | 2019-2023 | Grafix Pl |
| Stryker Corporation | $187.67 | 2019-2023 | Augment Injectable |
| Musculoskeletal Transplant Foundation INC. | $146.78 | 2019-2020 | |
| Wright Medical Technology, INC. | $105.18 | 2019 | |
| Abbvie INC. | $89.54 | 2023-2024 | Dalvance |
| Paratek Pharmaceuticals, INC. | $84.87 | 2023-2025 | Nuzyra |
| Abbott Laboratories | $68.37 | 2023 | Eterna |
| Tactile Systems Technology INC | $62.61 | 2020 | |
| Melinta Therapeutics, LLC | $43.76 | 2019 | |
| Nabriva Therapeutics, Plc | $42.66 | 2021-2022 | |
| Aroa Biosurgery Incorporated | $25.81 | 2020 | |
| Kci USA, INC. | $22.94 | 2021 | |
| Heron Therapeutics, INC. | $20.10 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $16.31 | 2025 | Integra |
| Ermi LLC | $14.94 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jorge Cuza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.